Yahoo India Web Search

Sign In

Search results

  1. Top stories

    View all

  2. www.livemint.com › market › stock-market-newsSun Pharma shares hit 52-week high despite legal wrangle with ......

    2 days ago · Sun Pharma stocks were trading in the green, up 2.26 per cent at ₹1,656.30 on July 25 at 2:13 pm on the BSE. The company has a market capitalisation of ₹3,97,212.20 crore.

  3. www.moneycontrol.com › news › businessUSFDA approves Sun Pharma's drug to treat alopecia areata -...

    2 days ago · July 26, 2024 / 11:10 AM IST. USFDA approves Sun Pharma's drug to treat alopecia areata. Sun Pharmaceutical Industries Ltd on Friday said the US health regulatory has approved its LEQSELVI ...

  4. economictimes.indiatimes.com › sun-pharmaceutical-industries-ltd › stocksupdateSun Pharmaceutical Industries News - The Economic Times

    Jul 18, 2024 · Sun Pharma. News. All News Announcement Recos. Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement. | News. 25 Jul 2024, 07:57AM IST. Mayne Pharma sued India's Sun Pharma for allegedly infringing patents on IMVEXXY, a drug for menopause-related vaginal pain.

  5. sunpharma.com › wp-content › uploadsSun Pharma to Acquire Concert Pharmaceuticals, Advancing the...

    Jan 19, 2023 · Sun Pharma to Commence Tender Offer to Acquire All Outstanding Shares of Common Stock of Concert. Upfront Cash Payment of $8.00 per Share of Common Stock, or Equity Consideration of $576 Million, and Contingent Value Right for up to $3.50 per Share of Common Stock on Achievement of Certain Time-Based Net Sales Milestones.

  6. www.moneycontrol.com › news › businessSun Pharma Q4 results: Net profit rises 34% to Rs 2,654. ... -...

    May 22, 2024 · Pharma major Sun Pharmaceutical Industries Ltd. on May 22 reported a better-than-expected consolidated net profit of Rs 2,654.5 crore for the March quarter, up 34 percent from the year-ago...

  7. www.reuters.com › business › healthcare-pharmaceuticalsIndia's top drugmaker Sun Pharma beats Q2 profit view | Reuters

    Nov 1, 2023 · HYDERABAD, Nov 1 (Reuters) - Sun Pharmaceutical Industries (SUN.NS), India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by...

  8. www.reuters.com › business › healthcare-pharmaceuticalsIndia's Sun Pharma beats Q3 profit view on strong domestic, US...

    Jan 31, 2024 · India's largest drugmaker Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in the key domestic and U.S. markets.

  9. www.livemint.com › companies › company-resultsSun Pharma net up 16.5% at ₹2,524 crore on robust sales | Mint

    Jan 31, 2024 · New Delhi: Sun Pharmaceutical Industries Ltd on Wednesday posted a consolidated net profit of ₹ 2,523.75 crore, an increase of 16.5% year-on-year (y-o-y), on the back of robust sales, volume...

  10. www.hindustantimes.com › business › sun-pharma-q2-results-profit-rises-5-on-strongSun Pharma Q2 results: Profit rises 5% on strong sales of generic...

    Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by strong sales in its domestic and U.S....

  11. www.moneycontrol.com › news › businessSun Pharma Q4 preview: Strong speciality drug sales, Revlimid ...

    May 22, 2024 · Sun Pharmaceutical Industries is expected to post a 22 percent increase in earnings in the January-March quarter, driven by strong sales of its specialty drugs, contribution from blockbuster...